Search

Financial results - CORINA'S ALL PHARMACEUTICS SRL

0.00
Financial Summary - Corina's All Pharmaceutics Srl
Unique identification code: 23568094
Registration number: J02/553/2008
Nace: 4773
Sales - Ron
198.053
Net Profit - Ron
-6.659
Employees
2
Open Account
Company Corina's All Pharmaceutics Srl with Fiscal Code 23568094 recorded a turnover of 2024 of 198.053, with a net profit of -6.659 and having an average number of employees of 2. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Corina's All Pharmaceutics Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 243.807 235.791 259.466 271.876 243.575 268.356 253.721 249.367 204.806 198.053
Total Income - EUR 251.056 239.488 264.012 276.573 255.030 274.357 260.596 253.897 207.512 200.339
Total Expenses - EUR 222.603 237.549 251.942 288.088 263.322 261.940 265.258 255.041 210.465 202.147
Gross Profit/Loss - EUR 28.453 1.940 12.070 -11.515 -8.292 12.416 -4.662 -1.144 -2.953 -1.808
Net Profit/Loss - EUR 23.600 1.492 9.574 -14.282 -10.784 9.870 -6.953 -3.632 -4.986 -6.659
Employees 2 2 3 3 3 3 3 3 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -2.8%, from 204.806 euro in the year 2023, to 198.053 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Corina's All Pharmaceutics Srl

Rating financiar

Financial Rating -
CORINA'S ALL PHARMACEUTICS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Corina's All Pharmaceutics Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Corina's All Pharmaceutics Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Corina's All Pharmaceutics Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Corina's All Pharmaceutics Srl - CUI 23568094

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 11.844 12.072 27.640 24.440 11.575 7.865 4.535 2.007 1.570 1.167
Current Assets 72.790 67.122 71.787 55.647 52.683 58.911 60.023 50.630 36.647 42.690
Inventories 49.381 56.056 41.541 16.252 24.423 24.561 30.594 24.685 19.627 29.546
Receivables 14.866 9.430 23.029 28.502 21.055 23.168 23.279 21.276 13.584 12.474
Cash 8.543 1.636 7.216 10.893 7.205 11.181 6.150 4.669 3.436 670
Shareholders Funds 30.174 31.359 40.402 25.379 14.103 23.706 16.227 6.867 1.860 -4.810
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 54.460 47.836 59.024 54.708 50.155 43.070 48.331 45.771 36.357 48.667
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 42.690 euro in 2024 which includes Inventories of 29.546 euro, Receivables of 12.474 euro and cash availability of 670 euro.
The company's Equity was valued at -4.810 euro, while total Liabilities amounted to 48.667 euro. Equity decreased by -6.659 euro, from 1.860 euro in 2023, to -4.810 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Corina's All Pharmaceutics Srl

Comments - Corina's All Pharmaceutics Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.